Skip to main content
Signal8
Evans Terry L profile photo

Terry L. Evans

CIK: 0002043317

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (26.7%)

Derivative conversions

Awards (A)11 (73.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENNEC PHARMACEUTICALS INC. logo
FENC

FENNEC PHARMACEUTICALS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Oct 31, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Oct 12, 2026
    Award(A)
    Direct
    2.3K shares at avg. $5.53$13K
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Sep 30, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Aug 31, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Jul 31, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Jun 30, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    May 31, 2026
    Award(A)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Apr 30, 2026
    Exercise(M)
    Direct
    168 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 31, 2026
    Exercise(M)
    Direct
    18.5K shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 31, 2026
    Award(A)

    Stock Options

    Direct
    120K shares at avg. $5.77-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 31, 2026
    Exercise(M)
    Direct
    171 shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 28, 2026
    Exercise(M)
    Direct
    2.1K shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 28, 2025
    Award(A)

    Restricted Share Unit

    Direct
    10K shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Mar 28, 2025
    Award(A)

    Restricted Share Unit

    Direct
    10K shares-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Nov 13, 2024
    Award(A)

    Stock Options

    Direct
    150K shares at avg. $4.23-

1-15 of 15

About Evans Terry L

Evans Terry L (SEC CIK 0002043317) files insider reports with the SEC as Chief Commercial Officer of FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 13 ownership filings by Evans Terry L (1 Form 3, 12 Form 4), filed between Nov 4, 2024 and Nov 2, 2026. Those filings report 15 transactions, from Nov 13, 2024 to Oct 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Evans Terry L's filings is in RESEARCH TRIANGLE PARK, NC.

Recent filings by Evans Terry L

  • Oct 31, 2026: Grant or award of FENC shares (Form 4, code A).
  • Oct 12, 2026: Grant or award of FENC shares (Form 4, code A).
  • Sep 30, 2026: Grant or award of FENC shares (Form 4, code A).
  • Aug 31, 2026: Grant or award of FENC shares (Form 4, code A).
  • Jul 31, 2026: Grant or award of FENC shares (Form 4, code A).

Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)

How to read Form 4 transaction codes